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technical success and low morbidity and mortality. The
analysis indicates that there was no significant effect of
run-off score upon time to recurrence of symptoms. Limb
salvage can be achieved even if options to restore inline flow
are limited. Our results show that restoration of inline flow
in most patients with critical ischemia is not necessary.
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Limb Ischemia (CLI) Apply to Everyday Vascular Sur-
gery Practice?
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Cronenwett1, Richard J. Powell1. 1Section of Vascular
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San Francisco, CA
Objectives: Recent efforts to develop standardized
metrics for outcomes in lower extremity revascularization
for CLI have led the SVS to develop OPGs, based on
aggregate data from randomized trials. It remains unknown
if these OPGs can be achieved in everyday vascular surgery
practice.
Methods: In accordance with SVS OPG criteria, we
studied all patients undergoing lower extremity bypass
surgery (LEB) for CLI within the Vascular Study Group of
New England (VS GNE). Each of the individual OPGs was
calculated in the VS GNE dataset and compared to pub-
lished SVS OPGs.
Results: We studied 838 patients who underwent 1,
063 LEB procedures. The primary efficacy endpoint, free-
dom from perioperative (30 day) death or any major ad-
verse limb event at one year, was similar between VS GNE
(75%, 95% CI 71-78%) and SVS OPG (77%, 95% CI
74-80%) (p  0.47). There were no significant differences
between the SVS OPGs and VS GNE results in most safety
or efficacy outcomes (Table). High-risk clinical (age80
years and tissue loss), anatomic (infra-popliteal anatomy),
or conduit (lack of single segment saphenous vein) catego-
ries derived from the SVS OPG cohort provided similar
discrimination of risk in the VS GNE dataset.
Conclusions: Community and academic centers in
everyday practice can meet OPGs derived from centers of
excellence in randomized trials of LEB. Quality improve-
ment initiatives, as well as clinical trials, should incorporate
OPGs in their outcome measures.Safety and Efficacy OPGs: Comparison of SVS -OPG and
the VS GNE Cohorts
Safety Outcomes
at 30 Days
SVS OPG Cohort
(mean, 95% CI)
Objective
Performance
Goal (OPG)
VS GNE Cohort
(mean, 95% CI)
p value
(SVS -OPG
vs VS GNE)
Above-Ankle
Amputation
1.9% (1.1-3.1%) 3% 1.0% (0.8-2.0%) p  NS
Major Adverse Limb
Events
6.1% (4.6-7.9%) 8% 2.5% (1.2-3.4%) p  0.04
Major Adverse
Cardiovascular
Events
6.2% (4.7-8.1%) 8% 4.2% (3.3-5.4%) p  NS
Efficacy Outcomes
at 1 Year
SVS OPG Cohort
(mean, 95% CI)
Objective
Performance
Goal (OPG)
VS GNE Cohort
(mean, 95% CI)
p value
(SVS -OPG
vs VS GNE)
Freedom From
Major Adverse
Limb Events or
Death
76.9% (74.0-79.9) 71% 76.3% (72.7-79.4) p  NS
Limb Salvage 88.9% (86.7-91.1) 84% 90.9% (88.2-93.0) p  NS
Survival 85.7% (83.3-88.1) 80% 91.6% (88.0-93.5) p  NS
Amputation-Free
Survival
76.5% (73.7-79.5) 71% 83.5% (79.0-86.2) p  NS
Freedom From
Reintervention or
Amputation
61.3% (58.0-64.9) 55% 73.2% (69.5-76.4) p  0.04
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The Use of Distal Arterial Access for Difficult Femoro-
popliteal Subintimal Angioplasty
George H. Meier, Paul Jones, Joseph S. Giglia. University
of Cincinnati, Cincinnati, OH
Objectives: As more challenging patients are subjected
to endovascular treatment of femoropopliteal occlusions,
technical failure is inevitable. Nonetheless, in a subset of
patients with a patent distal trifurcation vessel, retrograde
arterial access from the foot may be possible. This review
was undertaken to define the technique and use of distal
arterial access in treatment of femoropopliteal occlusions.
Methods: The records of all femoropopliteal subinti-
mal angioplasties done between September, 2007 and De-
cember, 2009 were reviewed with specific attention to the
use of distal arterial access in conjunction with conventional
access. Arteries approached, segments treated, and techni-
cal success was reviewed. Patency was documented by
clinical exam and confirmed by noninvasive lab evaluation
with specific attention to the distal access artery used.
Results: Approximately 250 femoropopliteal occlu-
sions were treated by subintimal angioplasty during this
interval. Of these, 14 patients required both proximal and
distal arterial access to treat their occlusions. The dorsalis
pedis artery was used for distal access in nine of these
patients while the posterior tibial artery was used in the
remaining five. All distal access was performed as a second
procedure after an initial diagnostic arteriogram and failed
